Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 475

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Encephalitis and GABA B receptor antibodies: Novel findings in a new case series of 20 patients

Open access
Höftberger, Romana, Titulaer, Maarten J., Sabater, Lidia, Dome, Balazs, Rózsás, Anita, Hegedus, Balazs, Hoda, Mir Alireza, Laszlo, Viktoria, Ankersmit, Hendrik Jan, Harms, Lutz, Boyero, Sabas, de Felipe, Alicia, Saiz, Albert, Dalmau, Josep, Graus, Francesc·2013·Neurology

Abstract

OBJECTIVE: To report the clinical features of 20 newly diagnosed patients with GABAB receptor (GABABR) antibodies and determine the frequency of associated tumors and concurrent neuronal autoantibodies. METHODS: Clinical data were retrospectively obtained and evaluated. Serum and CSF samples were examined for additional antibodies using methods previously reported. RESULTS: Seventeen patients presented with seizures, memory loss, and confusion, compatible with limbic encephalitis (LE), one patient presented with ataxia, one patient presented with status epilepticus, and one patient presented with opsoclonus-myoclonus syndrome (OMS). Nineteen (95%) patients eventually developed LE during the course of the disease. Small-cell lung cancer (SCLC) was identified in 10 (50%) patients, all with LE. Treatment and outcome was available from 19 patients: 15 showed complete (n = 7) or partial (n = 8) neurologic improvement after steroids, IV immunoglobulins, or plasma exchange and oncologic treatment when indicated; 1 patient died of tumor progression shortly after the first cycle of immunotherapy, and 3 were not treated. Five patients with SCLC had additional onconeuronal antibodies (Ri, amphiphysin, or SOX1), and 2 without tumor had GAD65 and NMDAR antibodies, respectively. GABABR antibodies were not detected in serum of 116 patients with SCLC without neurologic symptoms. CONCLUSION: Our study confirms GABABR as an autoantigen of paraneoplastic and nonparaneoplastic LE and expands the phenotype of GABABR antibodies to ataxia, OMS, and status epilepticus. The long-term prognosis is dictated by the presence of a tumor. Recognition of syndromes associated with GABABR antibodies is important because they usually respond to treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3182a9585f

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 475

Metadata

Authors
Höftberger, R., Titulaer, M. J., Sabater, L., Dome, B., Rózsás, A., Hegedus, B., Hoda, M. A., Laszlo, V., Ankersmit, H. J., Harms, L., Boyero, S., de Felipe, A., Saiz, A., Dalmau, J., & Graus, F.
Venue
Neurology
Published
2013-10-22
Volume
81
Issue
17
Pages
1500-1506
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2153926223
Cited by
475
References
3
FWCI
18.24
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Encephalitis and GABA B receptor antibodies: Novel findings in a new case series of 20 patients. https://app.cochat.ai/papers/10.1212/wnl.0b013e3182a9585f
The paper
Höftberger, R., Titulaer, M. J., Sabater, L., Dome, B., Rózsás, A., Hegedus, B., Hoda, M. A., Laszlo, V., Ankersmit, H. J., Harms, L., Boyero, S., de Felipe, A., Saiz, A., Dalmau, J., & Graus, F. (2013). Encephalitis and GABA B receptor antibodies: Novel findings in a new case series of 20 patients. Neurology. https://doi.org/10.1212/wnl.0b013e3182a9585f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.